{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:53:39Z","timestamp":1790783619693,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.ejphar.2007.06.027","type":"journal-article","created":{"date-parts":[[2007,6,30]],"date-time":"2007-06-30T07:13:01Z","timestamp":1183187581000},"page":"231-239","source":"Crossref","is-referenced-by-count":152,"title":["Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model"],"prefix":"10.1016","volume":"571","author":[{"given":"Takukyu","family":"Sha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mie","family":"Sunamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Kitazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Ii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Iizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2007.06.027_bib1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(00)80009-4","article-title":"Double-blind randomized controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock","volume":"351","author":"Abraham","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2007.06.027_bib2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1084\/jem.20031076","article-title":"Lipopolysaccharide interaction with cell surface toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14","volume":"198","author":"Akashi","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2007.06.027_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-2478(02)00228-6","article-title":"Recognition of pathogen-associated molecular patterns by TLR family","volume":"85","author":"Akira","year":"2003","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ejphar.2007.06.027_bib4","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-\u03baB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2007.06.027_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nature02761","article-title":"Inferences, questions and possibilities in Toll-like receptor signaling","volume":"430","author":"Beutler","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2007.06.027_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/bja\/77.1.110","article-title":"Sepsis and cytokines: current status","volume":"77","author":"Blackwell","year":"1996","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2007.06.027_bib7","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0306-3623(95)02141-8","article-title":"Hypothermia as an indicator of the acute effects of lipopolysaccharides: comparison with serum levels of IL1\u03b2, IL6 and TNF\u03b1","volume":"27","author":"Blanque","year":"1996","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.027_bib8","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2007.06.027_bib9","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0090-1229(89)90003-2","article-title":"Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacologic intervention","volume":"53","author":"Butler","year":"1989","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.ejphar.2007.06.027_bib10","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/1521-4141(200108)31:8<2448::AID-IMMU2448>3.0.CO;2-N","article-title":"The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol","volume":"31","author":"Byrd-Leifer","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejphar.2007.06.027_bib11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.7326\/0003-4819-119-8-199310150-00001","article-title":"Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome","volume":"119","author":"Casey","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2007.06.027_bib12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature01326","article-title":"The immunopathogenesis of sepsis","volume":"420","author":"Cohen","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2007.06.027_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00024382-199801000-00001","article-title":"Animal models of sepsis and shock: a review and lessons learned","volume":"9","author":"Deitch","year":"1998","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2007.06.027_bib14","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1097\/01.CCM.0000127036.27343.48","article-title":"Why do animal models (sometimes) fail to mimic human sepsis?","volume":"32","author":"Esmon","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2007.06.027_bib15","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1001\/jama.271.23.1836","article-title":"Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial","volume":"271","author":"Fisher","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2007.06.027_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0047-6374(81)90037-3","article-title":"Body temperature in normal and endotoxin-treated mice of different ages","volume":"16","author":"Habicht","year":"1981","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ejphar.2007.06.027_bib17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2007.06.027_bib18","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1124\/mol.105.019695","article-title":"A novel cyclohexene derivative, TAK-242, selectively inhibits Toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling","volume":"69","author":"Ii","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.027_bib19","first-page":"1289","article-title":"Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4","volume":"15","author":"Kato","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2007.06.027_bib20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock","volume":"345","author":"Landry","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2007.06.027_bib21","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/01.CCM.0000261883.16943.4B","article-title":"Sepsis since the discovery of Toll-like receptors: disease concepts and therapeutic opportunities","volume":"35","author":"Leaver","year":"2007","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2007.06.027_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<373::AID-PATH593>3.0.CO;2-3","article-title":"Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy?","volume":"190","author":"Lehr","year":"2000","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejphar.2007.06.027_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/geno.1998.5677","article-title":"Identification of a locus on distal mouse chromosome 12 that controls resistance to tumor necrosis factor-induced lethal shock","volume":"55","author":"Libert","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.ejphar.2007.06.027_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.arcmed.2004.07.006","article-title":"Molecular mechanisms involved in the pathogenesis of septic shock","volume":"35","author":"Lopez-Bojorquez","year":"2004","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ejphar.2007.06.027_bib25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1086\/367990","article-title":"Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia","volume":"187","author":"Lynn","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejphar.2007.06.027_bib26","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the Unite States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2007.06.027_bib27","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/ni1221","article-title":"Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3","volume":"6","author":"Martin","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2007.06.027_bib28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0002-9610(99)00216-0","article-title":"Attenuating tumor necrosis factor \u03b1 does not ameliorate other cytokine and peroxidase products during sepsis","volume":"178","author":"Mazolewski","year":"1999","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.ejphar.2007.06.027_bib29","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.1073\/pnas.0600462103","article-title":"Trif-related adaptor molecule is phosphorylated by PKC\u03b5 during Toll-like receptor 4 signaling","volume":"103","author":"McGettrick","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2007.06.027_bib30","doi-asserted-by":"crossref","first-page":"16042","DOI":"10.1074\/jbc.M606781200","article-title":"Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance","volume":"282","author":"Medvedev","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2007.06.027_bib31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1079\/PNS2004378","article-title":"Anti-cytokine and anti-inflammatory therapies for the treatment of severe sepsis: progress and pitfalls","volume":"63","author":"Minnich","year":"2004","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.ejphar.2007.06.027_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/abio.1993.1449","article-title":"A fluorometric assay for the measurement of nitrite in biological samples","volume":"214","author":"Misko","year":"1993","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2007.06.027_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2174\/1568010043343633","article-title":"Endotoxin recognition molecules MD-2 and toll-like receptor 4 as potential targets for therapeutic intervention of endotoxin shock","volume":"3","author":"Miyake","year":"2004","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"10.1016\/j.ejphar.2007.06.027_bib34","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ni809","article-title":"Essential role of MD-2 in LPS responsiveness and TLR4 distribution","volume":"3","author":"Nagai","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2007.06.027_bib35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1471-4906(03)00079-6","article-title":"Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing?","volume":"24","author":"Netea","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejphar.2007.06.027_bib36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/jpet.300.1.200","article-title":"KF24345, an adenosine uptake inhibitor, suppresses lipopolysaccharide-induced tumor necrosis factor-\u03b1 production and leukopenia via endogenous adenosine in mice","volume":"300","author":"Noji","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.06.027_bib37","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/348550a0","article-title":"Interlenkin-1 receptor antagonist reduces mortality from endotoxin shock","volume":"348","author":"Ohlsson","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2007.06.027_bib38","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1378\/chest.103.2.565","article-title":"Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality","volume":"103","author":"Pinsky","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2007.06.027_bib39","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1084\/jem.189.4.615","article-title":"Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)","volume":"189","author":"Qureshi","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2007.06.027_bib40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nm0503-517","article-title":"Novel strategies for the treatment of sepsis","volume":"9","author":"Riedemann","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2007.06.027_bib41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/09680519040100041001","article-title":"Ligand-dependent Toll-like receptor 4 (TLR4)-oligomerization is directly linked with TLR4-signaling","volume":"10","author":"Saitoh","year":"2004","journal-title":"J. Endotoxin Res."},{"key":"10.1016\/j.ejphar.2007.06.027_bib42","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/infdis\/162.2.421","article-title":"Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-\u03b1 in experimental gram-negative shock","volume":"162","author":"Silva","year":"1990","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejphar.2007.06.027_bib43","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.4049\/jimmunol.172.9.5727","article-title":"Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of Toll-like receptor 2-stimulated neutrophils","volume":"172","author":"Strassheim","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2007.06.027_bib44","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nm1231","article-title":"Thromboxane A2 and prostaglandin F2\u03b1 mediate inflammatory tachycardia","volume":"11","author":"Takayama","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2007.06.027_bib45","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1567-5769(01)00010-8","article-title":"Toll-like receptors; their physiological role and signal transduction system","volume":"1","author":"Takeuchi","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2007.06.027_bib46","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1074-7613(00)80119-3","article-title":"Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components","volume":"11","author":"Takeuchi","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2007.06.027_bib47","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/330662a0","article-title":"Anti-cachectin\/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia","volume":"330","author":"Tracey","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2007.06.027_bib48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.shk.0000145936.31967.d7","article-title":"Neutrophil release, MIP-2 and TLR-4 expression during human and experimental sepsis","volume":"23","author":"Tsujimoto","year":"2005","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2007.06.027_bib49","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.4049\/jimmunol.169.12.6668","article-title":"A novel Toll\/IL-1 receptor domain-containing adapter that preferentially activates the IFN-\u03b2 promoter in the Toll-like receptor signaling","volume":"169","author":"Yamamoto","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2007.06.027_bib50","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00003246-199707000-00001","article-title":"Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment","volume":"25","author":"Zeni","year":"1997","journal-title":"Crit. Care Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907007340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907007340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T19:47:08Z","timestamp":1556567228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299907007340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":50,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0014299907007340"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.06.027","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}